Placebo for Losartan
Sponsors
Organon and Co, Arbor Pharmaceuticals, Inc.
Conditions
Hypertension
Phase 3
A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)
TerminatedNCT00447603
Start: 2007-05-24End: 2007-10-22Updated: 2024-06-18
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
CompletedNCT02235909
Start: 2015-03-30End: 2019-11-11Updated: 2025-02-25